|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 316.80 CHF | -0.35% |
|
+1.90% | +23.99% |
| Dec. 12 | US FDA approves Innoviva's oral antibiotic for gonorrhea | RE |
| Dec. 12 | Natera and MEDSIR to Collaborate on the Mirador Trial in Breast Cancer | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5d. change | Varia. Jan 1. | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROCHE HOLDING AG | Other Pharmaceuticals | -0.35% | +1.90% | +23.99% | +25.12% | +4.12% | 340B |  | | |
Technical Rankings Surperformance
- Stock Market
- Equities
- ROG Stock
- Charts Roche Holding AG
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
